ITP (immune thrombocytopenia) is an autoimmune disorder where the body attacks its own blood platelets. This leads to a ...

An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions ...

An expert discusses the clinical presentation and diagnosis of immune thrombocytopenic purpura (ITP), emphasizing that ...

While current ITP therapies focus on increasing the platelet count to reduce the risk of bleeding, GlycoNet researchers are seeking to address the disease closer to its source, says Dr. Elizabeth ...

The researchers found that for these people, the AZ jab was associated with a slightly increased risk of ITP up to 27 days after vaccination. The disorder can cause minor bruising in some patients and ...

"Today`s FDA approval of Promacta for children with chronic ITP, a rare and potentially serious blood disorder, gives new hope to patients and their families," said Bruno Strigini, President ...

It is estimated that up to 100 people per million live with ITP. The disorder is considered chronic when symptoms last more than 12 months. 4 Long-term, primary chronic ITP is associated with ...

What causes ITP? According to the National Library of Medicine, ITP is a blood disorder caused by a reaction in which the immune system destroys platelets by mistake, affecting the blood’s ability to ...

About Immune Thrombocytopenia (ITP) Immune thrombocytopenia (ITP) is a disorder that can lead to easy or excessive bruising and bleeding. The bleeding results from unusually low levels of platelets.

This is ITP. ‘Immune thrombocytopenia (ITP) is an auto immune disorder that can lead to easy or excessive bruising and bleeding.